16 年
手机商铺
入驻年限:16 年
客服部
北京
技术服务、试剂、抗体、细胞库 / 细胞培养、ELISA 试剂盒
生产厂商

Complement component 3重组蛋白|Recombinant Mouse Complement component 3 Protein (His Tag)
品牌:Sino Biological
¥4520 - 29350
咨询公司新闻/正文
1148 人阅读发布时间:2021-06-25 15:36

| 毒株 | 货号 | 抗原 | 突变位点 | 标签 |
| B.1.617 | 40588-V07E16 | N | D377Y | His |
| B.1.617 | 40588-V07E20 | N | R203M, D377Y | His |
| B.1.617.2 | 40588-V07E29 | N | D63G, R203M, D377Y | His |
| B.1.617.3 | 40588-V07E30 | N | P67S, R203M, D377Y | His |
| B.1.617 | 40591-V08H19 | S1 | D614G, E154K, E484Q, L452R, P681R | His |
| B.1.617 | 40589-V08B12 | S1+S2 ECD | D614G, E154K, E484Q, E1072K, K1073R, L452R, P681R | His |
| B.1.617 | 40592-V08H28 | RBD | L452R | His |
| B.1.617 | 40592-V08H81 | RBD | E484Q | His |
| B.1.617/B.1.617.1/b.1.617.3 | 40592-V08H88 | RBD | L452R,E484Q | His |
| B.1.617/B.1.617.1/b.1.617.3 | 40592-V02H2 | RBD | L452R,E484Q | Fc |
| B.1.617.2 | 40592-V08H90 | RBD | L452R, T478K | His |
| B.1.617.2 | 40592-V08H91 | RBD | T478K | His |
| A/Victoria/2570/2019 (H1N1) Recommended for Egg-based (quadrivalent,trivalent) Vaccine HA: 40787-V08H, 40787-V08H1 NA: 40785-V08B NP: 40774-V08B |
A/Wisconsin/588/2019 (H1N1) Recommended for Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40787-V08H, 40787-V08H1 NA: 40785-V08B NP: 40774-V08B |
| B/Washington/02/2019 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40722-V08H NA: 40790-V08B NP: 40755-V08B |
B/Phuket/3073/2013 Recommended for Egg-based, Cell- or recombinant-based (quadrivalent) Vaccine HA: 40498-V08B NA: 40502-V07B NP: 40500-V08B |
| A/Cambodia/E0826360/2020 (H3N2) Recommended for Egg-based, Cell- or recombinant-based (quadrivalent, trivalent) Vaccine HA: 40789-V08H, 40789-V08H1 NA: 40784-V08B NP: 40778-V08B (Under Development) |
| CMV | EV-D68 | HAdV-B | HAdV-E |
| HPIV-3 | HPIV-4 | HMPV-A | HMPV-B |
| RSV | EBV | HCoV-229E | HCoV-HKU1 |
| HCoV-NL63 | HCoV-OC43 | MERS-CoV | SARS-CoV |
| EV-71 | CV |
| HIV | HBV | HCV |
| DENV | CHIKV | WNV | ZIKV | RVFV |
| EBOV | HTNV | HEV | VSIV |
| PCV2 | SIV | CyCMV | DcCoV |